FDA 483 OBSERVATION · #39 OF 1,945 MOST-CITED

Cleaning / Sanitizing / Maintenance

FDA cited this observation 587 times across 519 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs587
BY FISCAL YEAR
FY202660
FY202584
FY202456
FY202350
FY202240
FY202126
FY202034
FY201974
FY201870
FY201744
FY201649

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 117.35

The plant’s cleaning, sanitizing, and maintenance of equipment and utensils were inadequate to prevent contamination — either the activities were insufficient, or the maintenance of the cleaning state was not sustained.

Why FDA writes it — Cleaning and maintenance together keep equipment in a state that will not contaminate food. A one-time clean that is not maintained, or maintenance that neglects cleanability, both let contamination return — so FDA treats the combined cleaning-sanitizing-maintenance regime as a front-line control.

HOW TO COMPLY
  • Clean and sanitize equipment and utensils as necessary, and maintain them in a condition that prevents contamination.
  • Keep cleaning compounds, sanitizers, and the tools used to apply them controlled and stored to avoid becoming a contamination source themselves.
  • Follow documented cleaning and maintenance schedules and record their completion.
  • Repair or replace equipment that can no longer be effectively cleaned.
WHY FIRMS GET CITED
  • Cleaning treated as separate from maintenance, so a well-cleaned but deteriorating surface still contaminates.
  • No documented schedule, so lapses accumulate unseen.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.7× the rate of the average FDA-cited firm (36.4% vs 7.8%), across 519 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

Hain-Celestial Canada, ULC · Mississauga · Drugs · 2026-09-17

Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

USpharma, Ltd., Co. · Miami Lakes, Florida · Drugs · 2026-09-03

Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

Mylan Laboratories Limited (FDF-2) · Chhatrapati Sambhajinagar · Drugs · 2026-08-25

Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

Steril-Gene Life Sciences Private Ltd · Puducherry · Drugs · 2026-08-12

Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

Graviti Pharmaceuticals Private Limited · Hyderabad · Drugs · 2026-07-28

Equipment and utensils are not maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity, strength, quality or purity of the drug product.

Conopco Inc. d/b/a Unilever · Raeford, North Carolina · Drugs · 2026-07-13

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination control →Cleaning validation →Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →